FONT-SIZE Plus   Neg

BlueLinx Completes $40 Mln Rights Offering

BlueLinx Holdings Inc. (BXC) said Friday that it has completed its previously announced $40 million rights offering.

The company said previously that it would use the net proceeds of the rights offering of about $38.7 million to reduce the outstanding balance of its U.S. revolving credit facility.

Following the issuance of the newly subscribed shares, which is expected to occur on or about April 1, BlueLinx will have about 86.6 million total shares outstanding.

After giving effect to the offering, Cerberus ABP Investor LLC beneficially owns about 54.4% of BlueLinx' common stock.

Concurrent with the completion of the rights offering, BlueLinx's previously announced amendment and extension to its $400 million U.S. revolving credit facility became effective. As a result of the amendment and extension, the company's existing $400 million credit facility was increased by $22.5 million to $422.5 million and the maturity date was extended to April 15, 2016.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT